College of Life Sciences, South China Agricultural University, Guangzhou, Guangdong, PR China.
PLoS One. 2012;7(8):e42519. doi: 10.1371/journal.pone.0042519. Epub 2012 Aug 13.
The correct folding of a protein is a pre-requirement for its proper posttranslational modification. The Escherichia coli Sec pathway, in which preproteins, in an unfolded, translocation-competent state, are rapidly secreted across the cytoplasmic membrane, is commonly assumed to be unfavorable for their modification in the cytosol. Whether posttranslationally modified recombinant preproteins can be efficiently transported via the Sec pathway, however, remains unclear. ACP and BCCP domain (BCCP87) are carrier proteins that can be converted into active phosphopantetheinylated ACP (holo-ACP) and biotinylated-BCCP (holo-BCCP) by AcpS and BirA, respectively. In the present study, we show that, when ACP or BCCP87 is fused to the C-terminus of secretory protein YebF or MBP, the resulting fusion protein preYebF-ACP, preYebF-BCCP87, preMBP-ACP or preMBP-BCCP87 can be modified and then secreted. Our data demonstrate that posttranslational modification of preYebF-ACP, preYebF-BCCP87 preMBP-ACP and preMBP-BCCP87 can take place in the cytosol prior to translocation, and the Sec machinery accommodates these previously modified fusion proteins. High levels of active holo-ACP and holo-BCCP87 are achieved when AcpS or BirA is co-expressed, especially when sodium azide is used to retard their translocation across the inner membrane. Our results also provide an alternative to achieve a high level of modified recombinant proteins expressed extracellularly.
蛋白质的正确折叠是其正确翻译后修饰的前提条件。大肠杆菌 Sec 途径中,前体蛋白以未折叠的、易位相容的状态迅速穿过细胞质膜分泌,通常认为不利于其在细胞质中的修饰。然而,经过翻译后修饰的重组前体蛋白是否可以通过 Sec 途径有效地运输,目前尚不清楚。ACP 和 BCCP 结构域(BCCP87)是载体蛋白,分别可以被 AcpS 和 BirA 转化为活性磷酸泛酰巯基乙胺(holo-ACP)和生物素化-BCCP(holo-BCCP)。在本研究中,我们表明,当 ACP 或 BCCP87 融合到分泌蛋白 YebF 或 MBP 的 C 末端时,所得融合蛋白 preYebF-ACP、preYebF-BCCP87、preMBP-ACP 或 preMBP-BCCP87 可以被修饰,然后分泌。我们的数据表明,preYebF-ACP、preYebF-BCCP87、preMBP-ACP 和 preMBP-BCCP87 的翻译后修饰可以在易位之前在细胞质中发生,并且 Sec 机制可以容纳这些先前修饰的融合蛋白。当 AcpS 或 BirA 共表达时,可实现高水平的活性 holo-ACP 和 holo-BCCP87,尤其是当使用叠氮化钠阻止它们穿过内膜易位时。我们的结果还为实现高水平的修饰重组蛋白在细胞外表达提供了一种替代方法。